Int J Arrhythm.
2016 Mar;17(1):32-35. 10.18501/arrhythmia.2016.004.
NOAC in Asian
- Affiliations
-
- 1Division of Cardiology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
- KMID: 2308905
- DOI: http://doi.org/10.18501/arrhythmia.2016.004
Abstract
- Anticoagulation treatment, including novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs), is essential to prevent thromboembolic events in high-risk atrial fibrillation patients. There are not enough studies on the effect and safety of NOACs in Asians. Due to the low body surface area, genetic polymorphism, and herbal diet of Asians, it is difficult to attain optimal anticoagulation with traditional anticoagulation treatment using vitamin K antagonists, and more bleeding complications are reported with this treatment. In several recent studies, the use of NOACs in Asians resulted in lower thrombo- embolic events and fewer bleeding complications than those with a vitamin K antagonist. Given the race-related differences of Asians, NOACs have sufficient efficacy and safety for the prevention of thromboembolic events in patients with atrial fibrillation.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention
- A Recurrent Ischemic Stroke Stabilization after Using Non-Vitamin K Antagonist Oral Anticoagulant (NOAC)
- Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
- The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
- Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation
